adult T cell leukemia lymphoma therapy (Kyoto University/Miyazaki University/Chordia)

N/A

Report date: 2025/03/14 16:47:19
NME

Base Information

Drug Nameadult T cell leukemia lymphoma therapy (Kyoto University/Miyazaki University/Chordia)
Drug Alias Nameadult T cell leukemia lymphoma therapy (Kyoto University/Miyazaki University)ATLL therapy (Kyoto University/Miyazaki University/Chordia Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChordia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MiyazakiChordia Therapeutics IncKyoto University
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A